Offer - Urjas Oil for just ₹ 1
Tulixone is an allopathic medicine The correct dosage of Tulixone depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Tulixone is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Tulixone safe for pregnant women?
There are no side effects of Tulixone in pregnant women.
Is the use of Tulixone safe during breastfeeding?
Side effects of Tulixone on breastfeeding women are very mild.
What is the effect of Tulixone on the Kidneys?
Tulixone rarely affects the kidneys.
What is the effect of Tulixone on the Liver?
Very few cases of side effects of Tulixone on the liver have been reported.
What is the effect of Tulixone on the Heart?
Using Tulixone does not have any harmful effects on the heart.
Tulixone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tulixone unless your doctor advises you to do so -
Is this Tulixone habit forming or addictive?
Tulixone does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tulixone, you should not drive or work on any heavy machine, as Tulixone can make you drowsy.
Is it safe?
Yes, but take Tulixone only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Tulixone for mental disorders.
Interaction between Food and Tulixone
You can take Tulixone with food.
Interaction between Alcohol and Tulixone
Information about the interaction of Tulixone and alcohol is not currently available because this topic has not been researched yet.
Do not self-administer Tulixone. It comes in the form of injection and preferably taken 1 - 2 times in a day (Intravenously or Intramuscularly). Take this medicine in the required quantity and duration as prescribed by your doctor. Discontinuing the a in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 14 days course even after getting symptomatic relief. In case you feel any discomfort such as breathing difficulties and skin reactions while taking this medicine please inform your doctor immediately.
Occasionally Tulixone can cause a drug to induce hemolytic anemia (abnormal Red blood cell breakdown). However, if your blood reports are showing abnormal hemolytic anemia after taking this drug please discuss with your doctor.
Tulixone does not help in preventing cold, because a common cold is a viral infection. However, the drug can help in bringing relief from symptoms of cold, if it is associated with a bacterial infection. To treat cold take ample rest, maintain proper hygiene, gargle with saline water and seek medical advice if common cold symptoms persist for more than 7-8 days.
Tulixone and doxycycline can be taken together, as there are no reported harmful interactions between them. However, it doesn't mean that no interactions exist between them. Please take if prescribed by a doctor.
Yes Tulixone is used to treat typhoid fever. It is a second-line treatment for typhoid fever. If other antibiotics are resistant to salmonella typhi then it is very effective to treat typhoid fever. However, it is best to consult your doctor about the right treatment for typhoid fever.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
